Joachim Mierau

This inventor holds 15 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent, primarily in Pharmaceutical Compositions. Top assignees: Boehringer Ingelheim Kg, Boehringer Ingelheim Pharma Kg, Dr. Karl Thomae Gmbh. Active years: 1983-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joachim Mierau. Retrieved from https://idiyas.com/inventor/joachim-mierau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 6.4

ph-index = 7

Forward Citations = 301(Granted Patents)

Location History:

Mainz am Rhein, DE (2001)
Mainz, DE (1983 - 2002)

Company Filing History:

6 out of 197

Boehringer Ingelheim Kg

patents

4 out of 149

Boehringer Ingelheim Pharma Kg

Boehringer Ingelheim Gmbh

patents

5. 1 out of 9

C. H. Boehringer Sohn

Years Active: 1983-2002

Loading Chart...

Areas of Expertise:

Adenosine Antagonists

Antidepressant Activity

Xanthine Derivatives

Dopaminergic Disorders

Tetrahydrobenzothiazoles

Hexahydro-Benzazocines

Pharmaceutical Use

Medicaments

Amino Compounds

Benzamide Derivatives

Thiazole Compounds

Pharmacological Activity

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6492377 - Imidazotriazolopyrimidines with adenosine-antagonistic activity (2002-12-10),

2. 6387921 - Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions (2002-05-14),

3. 6355652 - Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions (2002-03-12),

4. 6191153 - Use of 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a pharmaceutical composition having an antidepressant activity (2001-02-20),

5. 6187780 - Assymetrically substituted xanthine derivatives having adenosine A1 antagonistic activity (2001-02-13),

6. 5719279 - Asymmetrically substituted xanthines (1998-02-17),

7. 5196454 - Method of treating disorders of the dopaminergic systems using (1993-03-23),

8. 5068325 - 4,5,7,8-tetrahydro-6H-thiazolo[5,4-d]azepines, their preparation and (1991-11-26),

9. 5053430 - Use of 2,7-diamino-1,2,3,4-tetrahydronaphthalenes as medicaments, new (1991-10-01),

10. 5006533 - Certain 3-bromo-2,6-dimethoxybenzamides and pharmaceutical use thereof (1991-04-09),

11. 4981862 - Tetrahydrobenzothiazoles, and the preparation and use thereof (1991-01-01),

12. 4886812 - Tetrahydro-benzthiazoles, the preparation thereof and their use as (1989-12-12),

13. 4843086 - Tetrahydro-benzthiazoles, the preparation thereof and their use as (1989-06-27),

14. 4731374 - Tetrahydro-benzthiazoles, the preparation thereof and their use as (1988-03-15),

15. 4393069 - 8-Arylalkyl-3-phenyl-3-nortropanols and salts thereof (1983-07-12),

Title: Joachim Mierau: A Visionary Inventor Driving Sustainable Innovation

Introduction:

Joachim Mierau, a renowned inventor hailing from Mainz, Germany, is a true pioneer in the world of inventions. His unwavering passion for innovation and commitment to creating a more sustainable future have positioned him as a trailblazer in the industry.

Latest Patents:

With an impressive portfolio of 15 patents to his name, Joachim Mierau continues to push the boundaries of possibility. Some of his latest patents include "Imidazotriazolopyrimidines with adenosine-antagonistic activity" and "Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions."

Career Highlights:

Having contributed significantly to the field of inventions, Joachim Mierau has made substantial strides in his career. His innovative spirit shines through in his work at Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG, where he has left an indelible mark on the industry.

Collaborations:

Collaboration is key to driving innovation forward, and Joachim Mierau understands this well. Throughout his career, he has worked alongside esteemed colleagues such as Gunter Schingnitz and Rudolf Bauer, fostering a culture of creativity and excellence.

Conclusion:

In conclusion, Joachim Mierau's dedication to innovation and sustainability sets him apart as a visionary inventor. His contributions continue to inspire positive change in the industry, leaving a lasting impact on the world of inventions.

Profile summary based on public USPTO records.